Privacy
Policy

Privacy Policy

Jazz Pharmaceuticals ("Jazz") respects your privacy and is committed to the protection of your personal information. Jazz Pharmaceuticals' Privacy Policy summarizes what personally identifiable information we may collect, and how we might use this information. Please be sure to read this entire Privacy Policy before using or submitting information to this site.

This Policy applies, in general, to all Internet sites operated by or on behalf of Jazz Pharmaceuticals.

Your Consent

By using this site, you agree to the terms of this Privacy Policy. Should you submit information to an Jazz Pharmaceuticals website, you are consenting to the collection, use, and disclosure of that information in accordance with this Privacy Policy.

Information You Provide Including Personally Identifiable Information

Jazz Pharmaceuticals collects information you knowingly and voluntarily provide to us, such as information you provide when signing up to receive e-mail alerts, completing a survey, or when asking us a question or providing feedback. This information may be personally identifiable information (i.e., name, address, telephone number, or e-mail). You will be informed what information is required and what information is optional. Remember, the only personally identifiable information Jazz Pharmaceuticals collects is the information you voluntarily provide.

Jazz Pharmaceuticals websites are not intended or designed to attract children under the age of 13. We do not knowingly collect personally identifiable information from visitors in that age group.

Information Collected Passively-Non Personally Identifiable Information

When you visit a Jazz Pharmaceuticals website, certain anonymous information may be passively collected through the use of cookies, Internet tags, or other navigational data collection including log files, server logs, or clickstream. Your Internet browser automatically transmits to our websites some of this anonymous information, such as the URL of the website you just came from and the Internet Protocol (IP) address and the browser version your computer is currently using. You may set your computer to notify you when a cookie is sent, or to refuse cookies, but refusing to accept cookies may not allow certain features of our websites to work properly.

Use and Disclosure of Information

Jazz Pharmaceuticals will not sell or rent personally identifiable information to any third party for any purpose. Jazz Pharmaceuticals may use the services of a third party to provide Jazz Pharmaceuticals with support services in connection with our websites and such parties may, from time to time, have access to your personally identifiable information to enable them to provide those services to Jazz Pharmaceuticals. Please take note that Jazz Pharmaceuticals requires all such third parties to meet the same standards of data protection as Jazz Pharmaceuticals and are prohibited from using the information for their own marketing purposes.

Jazz Pharmaceuticals uses personally identifiable information only for the purposes for which you provide it. In addition, Jazz Pharmaceuticals may use collected information, both personally identifiable and anonymous, to improve the content of our websites, to customize our websites to your preferences, to communicate information to you (if requested), for our internal marketing and research purposes, to analyze statistics and trends, and for any other purpose specified.

Non-personally identifiable information, such as info attained from cookies and tracking programs can be used for any purpose. They are primarily used by Jazz Pharmaceuticals to identify user interests and movement through our site and other sites. This information allows us to improve our website’s information, user experience and functionality offered to you. Cookies and tracking software may be placed into your hard drive to track your non personally identifiable information and viewing history for use by Jazz Pharmaceuticals.

How We Protect Your Personal Information

Jazz Pharmaceuticals is committed to protecting the security of your personal information. Jazz Pharmaceuticals takes reasonable steps to protect your information as you transmit it to our site and to protect such information from loss, misuse, and unauthorized access, disclosure, alteration, or destruction. Please keep in mind that no Internet transmission is ever completely secure or error free, and Jazz Pharmaceuticals cannot be responsible for breaches of security beyond our reasonable control.

Links to Other Websites

Jazz Pharmaceuticals websites may contain links to third-party websites as a service to you. Please note that this Privacy Policy does not apply to such third-party websites.

Changes to This Policy

We may occasionally update this Privacy Policy. Please review our Policy periodically, especially prior to providing personally identifiable information to us.

Indication

Elestrin is indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.

Important Safety Information

Estrogens, with or without progestins, should not be used for the prevention of cardiovascular disease or dementia. The use of estrogens and progestins has shown an increased risk of breast cancer, myocardial infarction, and pulmonary embolism. The use of estrogen, with or without progestins, has shown an increased risk of stroke, dementia, and DVT while estrogen alone therapy increases the risk of endometrial cancer. The most frequently reported adverse events in clinical trials were nasopharyngitis, breast tenderness, upper respiratory tract infection, and metrorrhagia.

Estrogen products should not be used in women with undiagnosed abnormal genital bleeding; known, suspected, or history of breast cancer; known or suspected estrogen-dependent neoplasia; active or history of deep vein thrombosis or pulmonary embolism; active or recent (within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction); liver dysfunction or disease; known or suspected pregnancy.

ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic measures, including endometrial sampling when indicated, should be undertaken to rule out malignancy in all cases of undiagnosed persistent or recurring abnormal vaginal bleeding. There is no evidence that the use of "natural" estrogens results in a different endometrial risk profile than synthetic estrogens at equivalent estrogen doses.

CARDIOVASCULAR AND OTHER RISKS Estrogens, with or without progestins, should not be used for the prevention of cardiovascular disease or dementia.

The Women's Health Initiative (WHI) estrogen alone substudy reported increased risks of stroke and deep vein thrombosis (DVT) in postmenopausal women (50 to 79 years of age) during 6.8 years and 7.1 years, respectively, of treatment with oral conjugated estrogens (CE 0.625 mg) per day relative to placebo.

The estrogen plus progestin WHI substudy reported increased risk of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women (50 to 79 years of age) during 5.6 years of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone acetate (MPA 2.5 mg) per day relative to placebo.

The Women's Health Initiative Memory Study (WHIMS), a substudy of the WHI study, reported increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 5.2 years of treatment with CE 0.625 mg alone and during 4 years of treatment with CE 0.625 mg combined with MPA 2.5 mg relative to placebo. It is unknown whether this finding applies to younger postmenopausal women.

Other doses of conjugated equine estrogens with medroxyprogesterone acetate and other combinations and dosage forms of estrogens and progestins were not studied in the WHI clinical trials and, in the absence of comparable data, these risks should be assumed to be similar. Because of these risks, estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.

Please see full Prescribing Information, including Boxed Warning and Patient Information Sheet.

You are encouraged to report negative side effects of prescription drugs to the FDA (Food and Drug Administration).
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information, call 1-800-890-3098.